The 4th Annual Cell & Gene Therapy Congress will be held on the 25-26 of October, 2018 in London, UK.
The congress will bring together key speakers Europe’s leading Pharmaceutical and Therapeutic companies, key regulatory bodies and prestigious research institutions to explore insights into the advances and clinical development of Cell & Gene Therapies, the key to success in their manufacture and commercialisation, and the future directions and challenges for Cell & Gene therapy.
Cell and Gene Therapy Catapult will be taking part in the following sessions:
Cost-Effectiveness in Cell & Gene Therapy Manufacture
Dr Ricardo Baptista, Lead Process Development Scientist
26th Oct, 08:30-09:30
Innovative Pricing Schemes for ATMPs
Dr Panos Kefalas, Head of Health Economics and Market Access
26th Oct, 12:00-12:30